Excelsior Sciences Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $25M

  • Investors
  • 8

Excelsior Sciences General Information

Description

Operator of an automated chemistry platform intended to accelerate the discovery and manufacture of small molecules. The company offers modular, synthesis-ready and AI-readable chemical building blocks used as tokens in a machine-executable chemical language, enabling researchers and industries working with small molecules to speed up development, generate new functional possibilities, and achieve more efficient and sustainable outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 345 Park Avenue South
  • 4th Floor
  • New York, NY 10010
  • United States
Primary Industry
Other Commercial Services
Other Industries
Biotechnology
Corporate Office
  • 345 Park Avenue South
  • 4th Floor
  • New York, NY 10010
  • United States

Excelsior Sciences Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Excelsior Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 03-Dec-2025 $25M Completed Startup
1. Early Stage VC (Series A) 03-Dec-2025 Completed Startup
To view Excelsior Sciences’s complete valuation and funding history, request access »

Excelsior Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Excelsior Sciences’s complete cap table history, request access »

Excelsior Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Excelsior Sciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cornucopian Capital Venture Capital Minority
Deerfield Management Venture Capital Minority
Empire State Development Government
Illinois Ventures Venture Capital Minority
Khosla Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Excelsior Sciences FAQs

  • When was Excelsior Sciences founded?

    Excelsior Sciences was founded in 2024.

  • Where is Excelsior Sciences headquartered?

    Excelsior Sciences is headquartered in New York, NY.

  • What is the size of Excelsior Sciences?

    Excelsior Sciences has 19 total employees.

  • What industry is Excelsior Sciences in?

    Excelsior Sciences’s primary industry is Other Commercial Services.

  • Is Excelsior Sciences a private or public company?

    Excelsior Sciences is a Private company.

  • What is Excelsior Sciences’s current revenue?

    The current revenue for Excelsior Sciences is .

  • How much funding has Excelsior Sciences raised over time?

    Excelsior Sciences has raised $70M.

  • Who are Excelsior Sciences’s investors?

    Cornucopian Capital, Deerfield Management, Empire State Development, Illinois Ventures, and Khosla Ventures are 5 of 8 investors who have invested in Excelsior Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process